Tag: acer therapeutics

January 2, 2019

Acer Therapeutics Announces In-license of Osanetant from Sanofi

Acer Therapeutics (Nasdaq:ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening...
October 29, 2018

Acer Therapeutics Submits NDA for EDSIVO for the Treatment of vEDS

Acer Therapeutics (Nasdaq:ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra-rare...